China has a long and illustrious history of fudging numbers and regulating what comes out as news from its non-porous borders. Consequently, a development that does not come as a surprise has emerged from the authoritarian nation where its leader Xi Jinping and his Politburo have been caught with their pants down. The Communist nation is now trying to artificially increase the efficacy percentage of its Sinopharm vaccine by only giving the vaccine jabs to its young and relatively healthy populace.
According to an Express report, Beijing is racing to vaccinate those aged between 18 and 59 who work for the government and public services so that the horrid numbers of the vaccine could be brought to a respectable level.
Chinese media outlets have released guidelines where it is stated that people above the age of 60 cannot be vaccinated, neither can those having pre-existing conditions such as high blood pressure and diabetes. More than a dozen diseases are noted in the guidelines and the vaccine jabs are only being given to a relatively healthy populace, according to NTD.
Hu Xijin, the editor-in-chief of the state-run, The Global Times, has even praised the CCP for focusing on vaccinating younger people.
Reported by TFI, a Shanghai-based vaccine expert Tao Lina has exposed the shocking risks associated with China’s Sinopharm vaccine. Tao has been working at the Shanghai Center for Disease Control and Prevention (SCDC) for the past 20 years. He has described the Chinese vaccine as the “most unsafe vaccine in the world,” after it was found to be having as many as 73 side effects.
Every vaccine has a few side-effects, but 73 adverse effects are just way over the top. Tao also asserted that the number of adverse reactions is “absolutely unprecedented.” He even mocked the user manual as “one long disclaimer.”
No detailed efficacy data of the vaccine has been publicly released, albeit the Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG) released a statement on Wednesday saying its vaccine was 79.34 percent effective in preventing people from developing the disease based on interim data.
While Sinopharm is inviting scathing criticism from the common Chinese folks as well as the International media, another Chinese vaccine is seemingly performing even worse than its counterpart.
Sinovac which is developing the CoronaVac vaccine to be deployed in foreign nations as part of Jinping’s vaccine diplomacy offensive charm has found no takers as the efficacy result data has not even crossed the minimum required threshold of safety.
Beijing’s decision not to vaccinate elderly population perhaps comes from the fact that the CCP does not want to get exposed as the elderly population will be much more vulnerable to the side effects of the vaccine
Reported previously by TFI, in order to publish false and fictitious data of CoronaVac’s efficacy, Chinese company Sinovac Biotech Ltd. had asked its Brazilian partners to withhold release of complete data.
It must be remembered that the 50% efficacy rate is a minimum standard set by US regulators for emergency authorization of Covid vaccines. For a country like China, however, which has engaged itself in a prestige battle against pharmaceutical majors like Moderna Inc. and Pfizer Inc., a 50 percent efficacy rate of its vaccine is a shameful loss of face.
The dubious Chinese vaccine had stirred controversy in Brazil, where even President Jair Bolsonaro had cast doubt on its prospective effectiveness. Jair had publicly rejected CoronaVac, saying Brazilians would not be used as guinea pigs.
China keeps on embarrassing itself on the world stage and rather than learning from its mistakes, Beijing continues to hide and bury its mistakes in the hope that no one sees it doing so. But so far, Jinping and his CCP haven’t been much successful in that particular endeavor.